ARKRAY reintroduces the CLIA waived DiaScreen 50 Urine Chemistry Analyzer

NewsGuard 100/100 Score

ARKRAY USA, Inc., a global leader of clinical chemistry, urine chemistry, and blood glucose products, today announced that it has re-introduced the CLIA waived DiaScreen® 50 Urine Chemistry Analyzer.

Back by popular demand, the DiaScreen® 50 satisfies a market need for a value priced analyzer. The DiaScreen® 50 enables easy in-office urine testing. It provides instrument read results that eliminate color interpretation variability between operators. An easy-to-read printout saves time and minimizes transcription errors. Patient identification may be entered with the keypad, barcode reader, or the keyboard of a connected computer.

The DiaScreen® 50 tests urine specimens for the presence of leukocytes, specific gravity, urobilinogen, glucose, ketone, bilirubin, protein, nitrite, blood, and pH. It uses the DiaScreen® Reagent Strips.

"We're very excited about the addition of the DiaScreen® 50 to our growing Point of Care product offering," said Jonathan Chapman, President of ARKRAY, USA. "Having just launched the SPOTCHEM(TM) EZ Chemistry Analyzer, ARKRAY USA is committed to bringing more products to the point of care marketplace."

SOURCE ARKRAY USA, Inc.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study reveals breakthrough in non-invasive detection of endometrial cancer